Eastern Illinois University

The Keep
Masters Theses

Student Theses & Publications

1999

Investigating the Allosteric Behavior of Malate
Dehydrogenase from Escherichia coli
Eman M. Ghanem
Eastern Illinois University

This research is a product of the graduate program in Chemistry at Eastern Illinois University. Find out more
about the program.

Recommended Citation
Ghanem, Eman M., "Investigating the Allosteric Behavior of Malate Dehydrogenase from Escherichia coli" (1999). Masters Theses.
1636.
https://thekeep.eiu.edu/theses/1636

This is brought to you for free and open access by the Student Theses & Publications at The Keep. It has been accepted for inclusion in Masters Theses
by an authorized administrator of The Keep. For more information, please contact tabruns@eiu.edu.

THESIS REPRODUCTION CERTIFICATE

TO:

Graduate Degree Candidates (who have written formal theses)

SUBJECT:

Permission to Reproduce Theses

The University Library is receiving a number of request from other institutions asking
permission to reproduce dissertations for inclusion in their library holdings. Although no
copyright laws are involved, we feel that professional courtesy demands that permission
be obtained from the author before we allow these to be copied.
PLEASE SIGN ONE OF THE FOLLOWING STATEMENTS:
Booth Library of Eastern Illinois University has my permission to lend my thesis to a
reputable college or university or the purpose of copying it for inclusion in that
institution's library or research holdings.

Author's Signature

Date

'

I respectfully request Booth Library of Eastern Illinois University NOT allow my thesis to
be reproduced because:

Author's Signature

tlieslS'l.lonn

Date

Investigating the Allos teric Behavior of
Mal ate Dehydrogenase from Escherichia coli
(TITlE)

BY
Eman M. Ghanem

11

7 ) -

THESIS
SUBMITIED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS
FOR THE DEGREE OF

Master of Science
IN THE GRADUATE SCHOOL, EASTERN ILLINOIS UNIVERSITY
CHARLESTON. ILLINOIS

1999
YEAR

I HEREBY RECON\MEND THIS THESIS BE ACCEPTED AS FULFILLING
THIS PART OF THE GRADUATE DEGREE CITED ABOVE

DATE

ADVISER

DATE

DEPAjf MENT HEAD

Investigating the Allosteric Behavior of Malate Dehydrogenase from
Escherichia coli

Thesis Approved by

Dr. N. C. Furumo

6-~-'i'i
Date

Dr. R. W. Chesnut

V)/11,1f "r
Dr. B. A. Lawrence

Date

ABSTRACT

Regulatory mechanisms of malate dehydrogenase from E.coli (eMDH)
involving NADH as an allosteric effector were investigated. The reaction was
studied in both directions: malate oxidation and oxaloacetate reduction. When
malate was the variable substrate, a plot of rate against substrate concentration
was sigmoidal in the presence of 0."065 mM NADH, which indicates the presence
of an allosteric site for NADH on the enzyme. Binding of NADH at the allosteric
site causes conformational changes in the active site and, thereby, changes the
catalytic activity of the enzyme. An increase in Km value, from 1.3 to 3.9 mM
malate was observed, which indicates a decrease in the enzyme affinity for the
substrate.
When eMDH was chemically modified with 5'-p-flurosulfonylbenzoyladenosine (FSBA) in the presence of 0.15 mM NADH as a protecting
agent, the allosteric behavior was abolished, which suggests that FSBA is
modifying specific amino acid residues in the allosteric site and, therefore,
preventing NADH from binding. eMDH was inactivated by FSBA in the absence
of NADH. The inactivation appears to result from covalent modification of His
177 in the active site, which is believed to be crucial for the catalytic mechanism
ofeMDH.
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Chapter I
INTRODUCTION

Enzymes are protein catalysts which catalyze the chemical reactions that
take place in biological systems. Essentially, all biochemical reactions that are
involved in metabolic pathways are enzyme-catalyzed. The rates of these
reactions could be as much as 1012 times greater than the corresponding
uncatalyzed reactions.
Enzymes can be distinguished from chemical catalysts by four
characteristic features: (1) they have higher reaction rates, (2) they function under
relatively mild conditions of temperature, pressure, and pH, (3) they are highly
stereospecific with respect to both substrates and products, and (4) they can be
regulated by a number of regulatory mechanisms.
Many enzymes catalyze reactions only in the presence of a specific nonprotein organic molecule, the coenzyrne or cofactor. Where the coenzyrne is
required, the complete system known as the holoenzyme, consists of the protein
(the apoenzyrne) plus the bound coenzyme. Most water soluble vitamins are
coenzymes precursors. For example, the nicotinamide component of NAO+ and
NADH (coenzyrnes that are involved in redox reactions) is derived from niacin,
one of the B complex vitamins.

In addition, enzymes display substrate saturation kinetics. In other words,
at low substrate concentration, [S], the reaction shows a first-order dependence
of the initial rates on [S]. However, instead of increasing indefinitely, at
sufficiently high [S], the rate approaches a limiting value termed the maximum
velocity, Vm•x' at which there is no dependency of the rate on [S] and, therefore,
the reaction becomes zero-order with respect to [S].
The concept of enzyme kinetics was developed by Michaelis and Menten
when they proposed the mechanism of an enzyme-catalyzed reaction [1 & 2].
Their mechanism supposes that the first step of the reaction is the binding of the
substrate (S) to the enzyme (E) to form an enzyme-substrate intermediate (ES).
The second step involves the conversion of the substrate to product (P), which is
released, with the regeneration of the free enzyme. This mechanism is presented
in Scheme (1):

ES

kcat

---11)111o~

E+P

Scheme (1)

where kcat is the catalytic constant and is related to v max and the total enzyme
concentration, [E] 0, by equation (1):
kcat

(1)

[E]O = V max

The concentration of the total enzyme, [E]0, is related to the concentration of the
free enzyme, [E], by equation (2):
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[E] = [E] 0 - [ES]

(2)

By applying the steady state approximation to [ES]:
d :~S]

= kl[E][S] - kcal [ES] - k_l [ES]= 0

(3)

Substituting [E]0 - [ES] for [E] in equation (3) and solving for [ES] gives equation
(4):

[ES]= [E]o [S]/ {[S] + (kcal + k-i)/ kl}

(4)

Since the initial rate, v =kcal [ES], it can be expressed by inserting the expression
for [ES] from equation (4), which gives equation (5):

kcat [E]o [S]
V=

(5)

[S] + ( kcat + k.1)/k1

where (kc.1+k_1)/k1 =Kmor the Michaelis constant, which is the substrate
concentration that produces half the maximum velocity. It is also a measure of
the affinity that an enzyme has for its substrate. The lower Km, the greater the
affinity between the enzyme and the substrate. Therefore, equation (5) can be
rewritten as equation (6):

V

= ( Vmax [S] ) / (Km+ [S] )

(6)

which is known as the Michaelis-Menten equation, which describes the
saturation behavior that was previously discussed.
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The regulation of enzyme activity sets them apart from non-enzyme
catalysts. Enzyme activity can be regulated by altering the enzyme concentration,
by the presence of inhibitors and/ or activators, by substrate availability, and by
chemical modification.
Allosterism is another regulatory mechanism that may control the
catalytic activity of enzymes. Typically, an enzyme contains an active site where
the substrate binds and initiates the chemical reaction. In addition to the active
site, some enzymes contain another binding site, the allosteric site. Low
molecular weight allosteric effectors (activator or inhibitor) control the catalytic
activity of these enzymes. Binding of the allosteric molecule at the allosteric site
causes conformational changes in the active site and therefore, changes the
catalytic activity of the enzyme, making it higher or lower. In this case, the
enzyme-catalyzed reaction does not follow Michaelis-Menten kinetics, which
gives a hyperbolic plot of rate vs. [S]. Instead, a plot of rate vs. [S] is sigmoidal or
has an "S" shape. Figure 1 shows the sigmoidal substrate saturation curve for an
allosterically regulated enzyme in the presence of the allosteric effector.
The sigmoidal character of a plot of v against [S] in the presence of an
allosteric inhibitor reflects the phenomenon of cooperativity. According to Figure
1, at low substrate concentration, the activity in the presence of the inhibitor is
low relative to that in its absence. However, as [S] increases, the extent of
inhibition becomes less severe. Therefore, allosterically regulated enzymes are
more sensitive to the relative concentrations of their substrates. The kinetics are

4

Figure 1.
Allosteric Behavior: Kinetic Evidence

~llosteric effector present

[Substrate]
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consistent with the presence of two or more interacting binding sites, where the
presence of an effector molecule at the allosteric site facilitates or inhibits the
binding of a substrate molecule at the active site.
Sigmoidal behavior can be described in several ways. The symmetry model of
allosterism by Monod, Wyman, and Changeaux, which is termed MWC theory,
is considered the most elegant model for describing cooperativity [2]. This model
is defined by four rules:
•

An allosteric enzyme is an oligomer.

+ The protein can exist in two conformational states, T (tense) and R (relaxed).
These states are in equilibrium whether or not a ligand (substrate) is bound to
the protein.

+ The T state has a lower affinity for the ligand and, therefore, is the less active
form.
+ The molecular symmetry of the protein is conserved during the

conformational changes.
Allosteric control could be due to the change of the R/T ratio. An allosteric
activator functions by binding to the R state and stabilizing it. An inhibitor
functions by binding to the T state and causes the transition to the R state to be
more difficult.
Allosterically regulated enzymes can be divided into two categories, K-series
and V-series [3]. For the K-series allosteric enzymes, the allosteric inhibitor
increases the Kmvalue and therefore, decreases the enzyme affinity for the

6

substrate without affecting Vmax· For the V-series enzymes, the inhibitor lowers
the catalytic efficiency of the enzyme by lowering Vmax without affecting Km.
As was mentioned earlier, Michaelis-Menten kinetics cannot be applied to the
substrate saturation curve in the presence of the allosteric effector. Instead, the
Hill equation:

v

Jog

Vmax - V

=

n Jog [S] - JogK

(7)

was derived to describe the allosteric behavior of proteins, where K is the
dissociation constant of the ligand. The value of "n", the slope of the equation, is
a measure of cooperativity. If n = 1, there is no cooperativity; if n > 1, there is
positive cooperativity.
This project is concerned with the regulatory aspects of malate
dehydrogenase from E.coli (eMDH). Dehydrogenases represent a class of
enzymes that catalyze the oxidation of an alcohol to a keto-group. eMDH
catalyzes the last step in the TCA cycle, the reversible oxidation of L-malate to
oxaloacetate with the subsequent reduction of NAD+to NADH, a coenzyme
utilized by most dehydrogenases (Figure 2). Although the equilibrium of this
0

reaction is in favor of malate/NAD• by a factor of 105 (L\G = +29.7 KJ I mol), in a
living cell, the net flux is toward the formation of oxaloacetate because it is
continuously removed by the first reaction of the TCA cycle, the condensation of
OAA with acetyl-CoA to form citrate.
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OH

Mai ate

NAD+
MDH

NA~ H+

0

co-2
Oxaloacetate

Figure 2. The Reaction Catalyzed by Malate Dehydrogenase (MOH)
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In eukaryotic organisms, MDH exists in two forms, the cytosolic and the
mitochondrial isozymes. Cytosolic MDH participates in the aspartate/malate
shuttle by which the cytosolic reducing equivalents are transported across the
mitochondrial membrane. Mitochondrial MDH participates on the other side of
the aspartate/ malate shuttle, in addition to catalyzing the formation of OAA.
eMDH was found to be closely homologous with mitochondrial MOH. It is a
dimeric protein that consists of two identical subunits; each with a molecular
weight of 35 kD [4]. Kinetic studies on eMDH have indicated that it, like other
MDH's, follows an ordered Bi Bi kinetic mechanism, in which NAD• binds first
followed by malate and OAA is released before NADH [5 & 6]. It was also
indicated that eMDH has a single ionizing group in the active site with a pKa
range between 7.8 and 8.5. This ionizing group is believed to be His 177, which
acts as a general acid/base in the catalytic mechanism of the enzyme [5].
In 1966, research by Kuramitsu showed that AMP, ADP, and ATP activate the

reaction catalyzed by eMDH in the direction of NAD• reduction [7]. According to
this observation, it is unlikely for these nucleotides to bind at the active site. It
was also observed that AMP decreases the Km value for NAD• from 3.7 to 0.79

mM and therefore, increases the enzyme affinity for NAD• without altering Vmax
of the reaction. This work has led to the proposal of the presence of an allosteric
site on eMDH where adenine nucleotides bind and alter the binding properties
in the active site.

9

Three years later, in 1969, Sanwal presented evidence that eMOH may be
regulated by NAOH in an allosteric manner [8]. When OAA was the variable
substrate, Sanwal showed eMOH to be allosterically regulated in the presence of
0.065 mM, 0.13 mM, and 0.32 mM NAOH. However, the plots of rate vs. [OAA]
under these conditions did not clearly present the sigmoidal curve, which
characterizes the allosteric behavior. This observation, in addition to Kuramitsu's
data, has led to the need of further investigations regarding the allosteric effect of
eMOH.
The work presented here focuses on studying the allosteric behavior of
eMOH in the presence of NAOH as the allosteric effector. The main purpose is to
determine whether or not NAOH allosterically regulates the reaction catalyzed
by eMOH. A kinetic tool was utilized which involved measuring the initial
reaction rates under different concentrations of the substrate (MAL or OAA) and
fixed concentrations of the cofactor (NAO+ or NAOH). The reaction was studied
in both directions: NAO+ reduction and NAOH oxidation.
Another tool utilized to study enzyme kinetics involves chemical
modification using reagents that can covalently bind to proteins. Binding of these
modifying reagents to specific amino acid residues that play a key role in
catalysis alters the catalytic activity of enzymes. In this project, eMOH was
chemically modified in order to determine the effect of this modification on the
allosteric behavior of the enzyme. The modifying agent used was
5'-p-flurosulfonylbenzoyladenosine (FSBA), shown in Figure 3.
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Figure 3.
The Structure of FSBA

OH

OH

FSBA was selected as the modifying agent since it has been found to be
involved in specific modification of nucleotide binding sites of a wide variety of

enzymes. Pyruvate kinase [9] and pig heart mitochondrial MOH [10] were
shown to be chemically modified and, therefore, inactivated by FSBA. In
addition, FSBA has the adenosine moiety, which makes it an appropriate analog
of NAO• and NADH (Figure 4). Previous work has shown that this moiety is
required for recognizing the active site of the enzyme being modified [9].
Different mechanisms that were proposed for the modification with FSBA are
discussed in Chapter IV.
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Figure 4.
The structure of NAD+ and NADH

Another aspect of this project, unrelated to regulation, is concerned with
strong hydrogen bonds, an interesting category of hydrogen bonds. Strong
hydrogen bond energies are in excess of 12 kcal/mol [11], and sometimes equal
those of covalent bonds. They have low-energy-barrier potential wells in which
the position of the proton is variable and sensitive to the molecular environment.
Therefore, they are referred to as low barrier hydrogen bonds (LBHB) or ionic
hydrogen bonds. A LBHB is characterized by large infrared stretching frequency
shifts and by relatively large downfield proton NMR chemical shifts (between 15
and20ppm).
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Hydrogen bonds are known to be involved in enzyme catalysis through
the formation of a structure called, the "charge-relay-system" between amino acid
residues in the active site. This structure serves to conduct electrons through the
hydrogen bonds [12 &13]. A LBHB was found to play an important role in the
catalytic mechanism of chympotrypsin through the formation and stabilization
of a tetrahedral intermediate between the enzyme and the substrate [14].
The crystal structure of eMDH in the presence of a substrate analog citrate
has shown that His 177 at the active site is within a hydrogen bond distance of
Asp 150, the bound citrate, and the cofactor [15]. NMR spectroscopy was utilized
in an attempt to investigate the hydrogen bonds within the active site and their
role in the catalytic mechanism of eMDH.

13

Chapter II
EXPERIMENTAL PROCEDURES

+ Chemicals and Instruments:
1. Chemicals:
All reagents were purchased from Sigma Chemical Company. E.coli
HB101 strain was obtained from American Type Culture Collection. Potassium
phosphate dibasic was obtained from Aldrich Chemical Company Inc. The
Bradford reagent and the Affi-Gel Blue agarose were obtained from Bio-Rad.

2. Instruments:
Centrifugation was performed on a Beckman Avanti J-30 I centrifuge at
4°C. The sonication of E.coli cell paste was performed on a Bronwill Scientific
Biosonik III sonicator. The enzyme assays were performed using a Simadzu UV3100 spectrophotometer with a thermostated microprocessor controlled cell
holder. Stopped-flow measurements were performed using an Applied
Photophysics Stopped-Flow Reaction Analyzer, SX-18 MV. Km and Vmax values
1

were calculated using the software "Enzfitter" by Robin J. Leatherbarrow. The H
NMR spectroscopy was performed at 300 MHz using a General Electronics QE300 Spectrometer.
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•

Preparation of E.coli Culture:
The E.coli HB101 strain colonies were used to inoculate 5 mL LB medium

that was incubated at 37° C for 18 hours with shaking at low speed in the shaker
room. When growth was observed, the cells were tested for the presence of
pEM6, which carries the MDH gene. This was done by using 50 µL of the
overnight culture to inoculate 3 test tubes, each one contained 5 mL LB medium
in addition to 50 µg I mL ampicillin (63 µL of 4 mg/ml ampicillin). The cells
were incubated at 37°C for 18 hours with shaking. The growth of E.coli colonies
in the presence of ampicillin indicated the presence of the pEM6 plasmid. The
contents of the test tubes were added to 3 one-liter flasks containing 1 liter of LB
medium, in addition to 50mg ampicillin. The flasks were incubated at 37°C for 18
hours with shaking at low speed. The culture was centrifuged at 4,000 RPM for
20 min at 4°C. The supernatant was decanted and discarded. The cell paste was
collected, weighted, and frozen until needed.

+ Enzyme Extraction and Purification:
Approximately 0.5 g of the cell paste was thawed and mixed with 25 ml of
10 mM potassium pohosphate (KPi) buffer pH 7.2 on ice with a magnetic stir bar.
The solution was then sonicated on ice at 65 % of the maximum power for 60
seconds. The solution was kept in ice for 60 seconds between sonications. This
process was repeated 5 times. The protein extract was then centrifuged at 4,000
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for 30 min at 4°C. The supernatant was assayed for activity and protein
concentration.
Approximately 25 ml of Affi-Gel Blue was washed with lL of 6 M urea
solution followed by deionized water and was then equilibrated with 10 mM I<Pi
buffer pH 7.2. The supernatant was mixed with blue agarose, and was allowed
to stand for 15 min at 4°C. This allowed the binding of eMDH to the blue agarose.
In the cold room, a column of the enzyme-bound blue agarose was built and
washed overnight with 10 mM KPi buffer pH 7.2 to remove any unbound
protein. The column was washed until the absorbance at 280 nm was less than
0.1. The enzyme was eluted from the column using 0 tol M NaCl gradient in 10
mM I<Pi buffer pH 7.2. Fractions of 3 ml each were collected and assayed for
enzyme activity. The fractions that showed high activity were combined and
assayed for activity and protein concentration. The eMDH was concentrated by
centrifugation at 2,000 RPM at 4°C using Centriplus concentrators. The
centrifugation was continued until the total volume was 10% of the volume of
the combined fractions. The concentrated protein was then assayed for total
activity and protein concentration.

+ The Enzyme Assay in the Forward Direction (Malate Oxidation):
Malate and NAD+were dissolved in 50 mM TAPS buffer pH 9.0
containing 100 mM KCl and 2 mM EDTA. The control assay was performed in
the direction of NAD+reduction and consisted of 7 mM NAD·, variable

16

concentrations of malate (0.15 to 12.0 mM), 50 mM TAPS buffer pH 9.0, 100 mM
KCl and 2 mM EDTA. The reaction began with the addition of 6.7 nM active site
MDH. The increase in the absorbance of NADH was recorded at 340 nm. In a
separate experiment, the assay was performed in the presence of 0.18 mM NAD•
instead of 7 mM as was stated in the literature (8).

•

The Enzyme Assay in the Reverse Direction ( OAA Reduction):
The routine assay for enzyme activity was performed in the direction of

NADH oxidation. Oxaloacetate and NADH were dissolved in 50 mM I<Pi buffer
pH 7.2 containing 100 mM KCl and 2 mM EDTA. The enzyme assay contained:
0.15 mM NADH, 0.10 mM OAA, 50 mM KPi buffer pH 7.2. The reaction was

started by the addition of 0.01 mL of the diluted MDH. The assay was performed
at 25°C. The decrease in NADH absorbance was recorded at 340 nm. The
number of units was calculated according to the equation:

MDH activity (u/mL) = (60D/min) (1/6.22) (0.01 mL)

(8)

where 6.22 mM' is the extinction coefficient of NADH at 340 nm, and 0.01 mL is
the volume of MDH.
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• The Allosteric Assay:
The allosteric assay contained the same conditions as the control assay in
the forward direction, in addition to the presence of 0.065 mM NADH as the
allosteric effector. The assay was performed at 25°C and the increase in
absorbance was recorded at 340 nm.

•

Protein Assay
The protein concentration was determined using 1 mL of Bradford

reagent, diluted 5-fold and 20 µL protein solution. The absorbance was recorded
against reagent blank at 595 nm at 25°C and the concentration was calculated
using the equation:

Protein cone. (mg/ mL) = (Abs + 0.0166) I 1.1887

(9)

The specific activity was calculated as the number of units/mg protein.
Chemical Modification
1) Treatment with 5'-p-flurosulfonyl benzoyl adenosine ( FSBA ):
FSBA was dissolved in absolute ethanol. The concentration of the stock
solution was 10 mM. The experiment was performed in the presence of NADH to
protect the active site from binding to FSBA. Two eMDH samples were prepared:
modified and control. The control sample consisted of: 300 nM MDH, 10%
absolute ethanol, 0.15 mM NADH, 50 mM TAPS buffer, pH 9.0 and 100 mM KCl.
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The modified sample contained the same concentrations except for the presence
of 0.1 mL of 10 mM FSBA. NADH was added before the addition of FSBA. The
two samples were incubated for 4 hours at room temperature. However, when
the samples were assayed for enzyme activity, a significant drop of the rates was
observed. As a result, the experiment was repeated with incubation time of one
hour at room temperature. After the incubation period, the enzyme was washed
using equal volume of 50 mM TAPS buffer pH 9.0 and centrifuged at 2000 RPM
for 20 min, after being loaded in Centriplus concentrators, at 4°C in order to
remove any unbound FSBA. The washing process was repeated 3 times.
In order to determine the effect of the modification, 10 µL aliquots from

the control and the modified samples were assayed in the forward direction in
the absence and presence of 0.065 mM NADH.
2) The Chemical Modification with FSBA without protecting the active site:
This experiment was performed in order to determine the role of NADH
in protecting the active site from being modified by FSBA, which in tum might
give an idea whether the FSBA is modifying the active site or the allosteric site.
In this experiment, two samples were prepared: protected and

unprotected eMDH. The unprotected enzyme sample consisted of: 690 nM
eMDH active sites, 0.1mMFSBA,50 mM TAPS buffer pH9.0. The protected
sample contained the same concentrations in addition to the presence of 0.15 mM
NADH. The two samples were incubated for 1 hour at room temperature and
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washed as was described previously. The control assay in the forward direction
was performed on both samples.

+ Allosteric Effect using the Stopped-Flow Spectrophotometer:
The experiment was performed in the Department of Chemistry,
University of Illinois, Urbana-Champaign using an Applied Photophysics
stopped-flow spectrophotometer. The stopped-flow technique allowed us to
record the exact initial rates of the reaction. The final volume of the assay was
100 µL. The control assay in the forward direction consisted of: variable
concentrations of malate (from 0.043 to 8.5 mM), 0.18 mM NAD·, 50 mM TAPS
buffer pH 9.0 and 100 mM KCL The increase in the NADH absorbance was
recorded at 340 nm and 25°C. The rates were recorded as the change of the
absorbance per second, which was converted to the change of the absorbance per
minute. The allosteric assay was performed under the same conditions, in
addition to the presence of 0.065 mM NADH as the allosteric effector.

+ The Allosteric Effect in the direction of NADH oxidation:
The purpose of this experiment was to determine whether or not eMDH is
allosterically regulated in the reverse direction, NADH oxidation. The
experiment was performed using both the conventional and the stopped-flow
spectrophotometers.
Both NADH and OAA were dissolved in 50 mM KPi buffer, pH 7.2. Three
different concentrations of NADH were used: 0.017 mM, 0.15 mM, and 0.32 mM.
The assay mixture consisted of variable concentrations of OAA (from 0.003 mM
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to 0.16 mM), NADH concentration was fixed, SO mM KPi buffer pH 7.2
containing 100 mM KCl, and 2 mM EDTA. The reaction was started by the
addition of 0.8 nM eMDH (0.16 nM active sites). The decrease in absorbance was
recorded at 340 nm and 25°C. Since the change in absorbance in the presence of
0.32 mM NADH was very small compared to the initial absorbance, the rates
recorded in this assay were measured against a 0.15 mM NADH blank.

+ The Chemical Modification with FSBA at pH 7.2:
The purpose of this experiment was to determi.r).e the effect of the chemical
modification on the allosteric behavior of eMDH in the reverse direction. The
enzyme was incubated with FSBA under the same conditions that were
described above. However, 50 mM KPi buffer pH 7.2, containing 100 mM KCl,

and 2 mM EDTA was used instead of the TAPS buffer. After the washing
process, the enzyme was diluted and used in the enzyme assay in the presence of
0.32 mM NADH.

+ Protein NMR Studies:
In order to run this experiment, high protein concentration was required.

Therefore, two eMDH extracts were combined, concentrated and lyophilized.

Protein Lyophlization (Freeze Drying):
The protein solution needed to be lyophilized for two reasons: 1) to
eliminate the water molecules, which will reduce the intensity of the water
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signal, and 2) to achieve the highest possible protein concentration. The protein
extract (approximately 1.9 mL) was frozen, in a 25 mL round bottom flask, using
liquid nitrogen and was then dried under vacuum for 3 to 4 hours or until all the
solution was converted to a white powder. The dry protein was then
reconstituted in 0.6 mL D20. At this point, there was some protein left that could
not be dissolved after swirling the solution on ice for approximately 15 min. As a
result, the protein solution was centrifuged at 3,000 RPM for 20 min at 4°C. The
supernatant was assayed for activity and protein concentration.
'H NMR Experiment:
The NMR spectra were recorded for the lyophilized protein with DSS as
an internal standard. The protein concentration was approximately 0.1mMin0.6

mL D20. The sweep width was 1000 ppm. In the first spectrum, the number of
acquisitions was 496 and D5 (relaxation time) was 1.5 sec. In order to improve
the signal-to-noise ratio, the second spectrum was obtained using 10512
acquisitions and D5 was 1.5 sec. All spectra were collected at 21°C.
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Chapter III
RESULTS

•

Purification of Malate Dehydrogenase:

Enzyme activity and protein concentration for the crude and purified
MDH are summarized in Table 1.

Table 1: Results of MDH purification.

Total Units
After
Extraction
After
Purification
After
Concentration

•

5082.5

Protein Cone.
(mg/ mL)
1.7

Specific Activity
(unit/ mg)
199.6

1686.6

0.042

787.4

1656.5

0.54

808.S

The Allosteric Assay:

In this experiment, malate concentration was varied from 0.15 to 12.0 mM,
NAD• and NADH concentrations were held constant at 7 mM and 0.065 mM
respectively. The buffer used was 50 mM TAPS pH 9.0containing100 mM KCL
The data from the control and the allosteric assays is summarized in Table 2, and
the plot of the rate vs. malate concentration is presented in Figure 5.

23

Table 2. The allosteric effect of eMDH in the presence of 0.065 mM NADH
Conditions: 0.15to12.0 mM malate, NAD• was fixed at 7 mM, NADH was
fixed at 0.065 mM, 50 mM TAPS pH 9.0 and 100 mM KCl
Malate cone.
(mM)

0.15
0.5
1.0
2.0
3.0
5.0
7.0
10.0
12.0

Rate

Rate (~OD I min)
With 0.065 mM NADH
0.003
0.004
0.007
0.050
0.062
0.075
0.090
0.096
0.120

(~OD/min)

Control
0.060
0.110
0.143
0.180
0.201
0.220
0.260
0.276
0.286

The sigmoidal curve in the presence of 0.065 mM NADH that is shown in
Figure 5 supports the proposal of the presence of an allosteric site where NADH
binds and changes the catalytic activity of eMDH.

• The Chemical Modification with FSBA:
The chemical modification experiment was performed to determine
whether or not FSBA will covalently bind to the allosteric site and affect the
binding of NADH at this site. The enzyme was incubated with 1 mM FSBA in the
presence of 0.15 mM NADH to protect the active site from being modified . Both
the control and the allosteric assays were performed on the control and the
modified enzyme. Tables 3 & 4 list the results of the control and the allosteric
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The Allosteric Effect of eMDH
0.40

Km= 1.05 mM ± 0.20 (19%)

0.35

Vmax = 0.29 ± 0.015 (5.2%)
0.30

Control, with no NADH present

•

0.25

•

•

10.0

12.0

Q)

~0.20

a:

0.15
0.10
0.05
0.00
0.0

2.0

4.0

8.0

6.0

14.0

[malate] (mM)

Figure 5.
A plot of the rate vs. [malate] in the absence and presence of 0.065 mM
NADH showing the allosteric behavior of eMDH
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assays for both the control and the modified eMDH respectively. The plots of this
data are presented in Figures 6 & 7.
Chemical Modification with FSBA
Control eMDH (not treated with FSBA)
Conditions: 7 mM NAD+, 0.15 to 12.0 mM malate, 0.065 mM NADH, 50 mM
TAPS pH 9.0 and 100 mM KCl
Table 3.

Malate cone. (mM)

Control Rate (60D/min)

0.15
0.5
1.0
2.0
3.0
5.0
7.0
10.0
12.0

0.023
0.030
0.043
0.054
0.060
0.073
0.081
0.080
0.081

Rate ( 60D/min)
with 0.065 NADH
0.0005
0.0006
0.0017
0.0077
0.0129
0.0210
0.0226
0.0225
0.0225

Chemical Modification with FSBA
Modified eMDH (treated with FSBA)
Conditions: 7 rnM NAD+, 0.15to12.0 mM malate, 0.065 mM NADH, 50 mM
TAPS buffer pH 9.0 and 100 mM KCI
Table 4.

Malate cone. (rnM)

Control Rate (60D/rnin)

0.15
0.5
1.0
2.0
3.0
5.0
7.0
10.0
12.0

0.008
0.013
0.016
0.020
0.025
0.034
0.040
0.041
0.041
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Rate ( 60D/min)
With 0.065 NADH
0.005
0.007
0.009
0.015
0.018
0.020
0.021
0.020
0.020

Chemical Modification with FSBA
Control eMDH
0.1
0.09
0.08

Km= 0.98 mM ± 0.19 (19%}
Vmax = 0 .096 ± 4.2 E-03 (4.4%}

Control, with no NADH present

•

•

0.07

-

0.06

<1>

co 0.05

a:

0.04
0.03

With 0.065 mM NADH

0.02
0.01
0.0

2 .0

4.0

6.0

8.0

10.0

12.0

14.0

[malate] (mM)

Figure 6.
Plot of rate vs. [MAL] in the absence and presence of NADH for the
control eMDH that was not treated with FSBA
Conditions: 0.15 to 12.0 mM Malate, 7 mM NAO+, 0.065 mM NADH,
and 50 mM TAPS buffer pH 9.0
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Chemical Modification with FSBA
Modified eMDH
0.045 . . . - - - - - - - - - - - - - - - - - - - - - - - - - - - - .
Control
Control
Km = 2.2 mM ± 0.5 (2.2.7%)
0.040

•

0.035
0.030

a:
Q)

0.025

CU

•

0.020

With 0.065 mM NADH

•

0.015
0.010

With 0.065 mM NADH

Km = 1.08 ± 0.22 (20.7%)
Vmax = 0.02 ± 1.2 E-03 (6%)

0.005

0.000 - - - - - - - - - - - - - - - . - - - - - - - - - - . - - - - - - - 12.0
14.0
10.0
2.0
4.0
6.0
8.0
0.0

[malate] (mM)

Figure 7.
Plot of rate vs. [MAL] in the absence and presence of NADH for the
modified eMDH that was treated with FSBA
Conditions: 0.15 to 12.0 mM malate, 7 mM NAO +, 0.065 mM NADH, and
50 mM TAPS buffer pH 9.0
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The eMDH sample that was treated with FSBA did not show the allosteric
behavior in the presence of 0.065 mM NADH, which suggests that FSBA may
have covalently modified a specific amino acid residue at the allosteric site and,
therefore, prevented the binding of NADH.
However, the data obtained from the allosteric assay in the presence of
NADH (Figure 5) was not reproducible when the assay was repeated several
times in order to confirm this behavior.
In addition, the control and the allosteric assays were also performed in
the presence of 0.18 mM NAD• as was stated in the literature instead of 7 mM [8].
Each data point of the assay in the presence of NADH was repeated three times
and the average was considered as the actual rate. Tables 5 & 6 list the results of
this assay. A p lot of this data is presented in Figure 8.

Table 5. The control assay using 0.18 mM NAD•

Malate cone. (mM)
0.15
0.5
1.0
2.0
3.0
5.0
7.0
10.0
12.0

Control Rate (~OD/min)
0.0030
0.0119
0.0235
0.0365
0.0501
0.0573
0.0721
0.0755
NA
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Table 6. Results from the allosteric assay at 0.18 mM NAD+ and 0.065

mM
[malate]
(mM)
0.15
0.5
1.0
2.0
3.0
5.0
7.0
10.0
12.0

Rate
(LiOD/min)
Trial# 1
0.0004
0.0051
0.0067
0.0145
0.0186
0.0289
0.0346
0.0394
NA

Rate
(LiOD/min)
Trial# 2
NA
0.0070
0.0126
0.0199
0.0224
0.0365
0.0367
NA
NA

Rate
(LiOD/min)
Trial# 3
0.0004
0.0037
0.0069
0.0177
NA
0.0335
NA
0.0361
0.0420

Average
rate
0.0004
0.0053
0.0087
0.0174
0.0205
0.0329
0.0357
0.0378
0.0420

As Figure 8 shows, the allosteric effect could not be detected using 0.18
mM NAD+. At this point, it was not clear whether or not eMDH is allostericaly
regulated by NADH. The fact that this behavior was observed in the first set of
data led to the idea of using a different technique to record the initial rates of the
reaction.
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The Enzyme Assay Using 0.18 mM NAO+
0.1
0.09
0.08

Control
Km= 3.5 mM ± 0.44 (12.6%)
Vmax= 0.104 ± 5.4 E- 03 (5.2%)

Control

•

0.07
0.06

.....roCl>

((

0.05
With 0.065 mM NADH

0.04
0.03
0.02

with 0.065 mM NADH

0.01

Km= 5.2 mM ± 0.9 (17.3%)
Vmax = 0.06 ± 4.9E-03 (8.2%)

o ---~~--.~~~--.-~~~......-~~--.~~~--.-~~~-.-~~--

o.o

2.0

4.0

6.0

8.0

10.0

12.0

[malate] (mM)

Figure 8.
Plot of rate vs. [MAL] using 0.18 mM NAO+ in the absence and the
presence of 0.065 mM NAOH
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14.0

• The Enzyme Assay usin g the Stopped-Flow Spectroph otometer:
The assay was performed using an Applied Photophysics stopped-flow
spectrophotometer, which allowed us to record the exact initial rates of the
reaction. In this experiment, lower concentrations of malate were used, varying
from 0.04 to 8.5 mM. NAD+ and NADH concentrations were held constant at 0.18
mM and 0.065 mM respectively. The rates were recorded as LiOD I sec., which
was converted to LiOD I min. Table 7 shows the rates of the reaction from the
control and the allosteric assays. A plot of v against [malate] is presented in
Figure 9.
Table 7. The rates obtained from the control and the allosteric assays
using the stopped-flow spectrophotometer.
Conditions: 0.0425 to 8.5 mM malate, 0.18 mM NAD+, 0.065 mM NADH,
and 50 mM TAPS pH 9.0.
Malate cone. (mM)
Rate (LiOD/min),
Rate (LiOD/min),
Control
WI 0.065 mM NADH
0.0425
0.0245
0.0047
0.0647
0.0101
0.085
0.213
0.1080
0.0219
0.425
0.1790
0.0476
0.850
0.4143
0.0795
1.70
0.800
0.1581
3.0
1.0448
0.3684
4.25
1.5190
0.6230
1.8280
8.5
0.6871

As Figure 9 shows, using lower concentrations of malate allowed the
detection of the allosteric effect of eMDH at 0.18 mM NAD·. The data obtained
from this assay were fit to the Hill equation and "n" value of 1.2 was obtained.
Figure 10 shows a plot of log v /Vm••-v against log [S].
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The Allosteric Effect Using the Stopped-Flow Spectrophotometer
2.0 - - - - - - - - - - - - - - - - - - - - - - - - - - 1.8
1.6

1.4

Km= 1.3 mM ± 0.12 (9.2%}
Vmax = 0.98 ± 0.13 (13.3%}

Control, with no NADH present

•

•

1.2
Cl>

-ea 1.0

a:

With 0.065 mM NADH

0.8
0.6

0.4
0.2

o.o . .~-T""""'"--r----.----r---,----r---..,---,.------1
2.0
1.0
3.0
4.0
5.0
0 .0
6.0
8.0
9.
7.0
[malate] (mM)

Figure 9.
Plot of rate vs. [MAL] using the stopped-flow spectrophotometer.
Conditions: 0.0425 to 8.5 mM malate, 0.18 mM NAO+, 0.065 mM NADH,
and 50 mM TAPS buffer pH 9.0
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The Hill Plot for eMDH in the Forward Direction (Malate Oxidation)

•
-1.5

-1

-0.5

15

-0.5

slope =1.2
2

R

=0.98

Km (malate) = 3.9 mM
K=6mM
-1.5

-2

log [malate]

Figure 10.
The Hill plot for the data obtained using the stopped-flow spectrophotometer
at 0.18 mM NAO+
Km was calculated as the substrate concentration when log vNmax - v = 0
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•

The Chemical Modification with FSBA, using 0.18 mM NAD• in the
enzyme assay:

The enzyme was incubated with FSBA under the same conditions that
were described previously. Tables 8 & 9 list the rates that were obtained from the
enzyme assays using the control and modified eMDH respectively. Figure 11
represents the control and the allosteric assays for the control eMDH (was not
treated with FSBA) with the sigmoidal curve in the presence of 0.065 mM
NADH. However, as Figure 12 shows, the FSBA did not completely block the
allosteric site, since the plot of the enzyme assay in the presence of NADH does
not follow Michaelis-Menten equation.
Since this behavior might be due to the incomplete substrate saturation of
eMDH at low concentration of NAD·, the enzyme assays were performed on the
same samples of eMDH using 7 mM NAD·. This data is presented in Tables 10
and 11. As figures 13 and 14 show, eMDH did not exhibit the allosteric effect
after being modified with FSBA.
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Chemical Modification with FSBA
Control eMDH that was not treated with FSBA
Conditions: 0.05 to 10.0 mM malate, 0.18 mM NAO·, 0.065 mM
NADH and 50 mM TAPS oH 9.0
Malate cone. (mM)
Rate ( 600 I min)
Rate ( 600 I min)
With 0.065 mM NADH
Control
0.05
0.005
0.002
Table 8.

0.10

0.009

0.003

0.25

0.019

0.004

0.5

0.032

0.004

1.0

0.048

0.013

2.0

0.086

0.023

5.0

NA

0.030

10.0

0.107

0.033

Chemical Modification with FSBA
Modified eMDH that was treated with FSBA
Conditions: 0.05 to 10.0 mM malate, 0.18 mM NAO·, 0.065 mM
NADH and 50 mM TAPS pH 9.0
Malate cone. (mM)
Rate (60D I min)
Rate (60D/min)
With 0.065 mM NADH
Control
0.05
0.003
0.0015
Table 9.

0.10

0.006

0.0035

0.25

0.011

0.0055

0.5

0.026

0.008

1.0

0.043

0.012

2.0

NA

0.026

5.0

0.084

0.039

10.0

0.092

0.039
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Chemical Modification with FSBA Using 0.18 mM NAO+
in the Enzyme Assay
Control eMDH
0.12 . . . . . . - - - - - - - - - - - - - - - - - - - - - - - - - - - - - .
Control
Km= 1 .3 mM ± 0.23 (16.7%)
V max = 0 .12 ± 8.1 E-03 (6.7%)
0.10

•

0.08
Q)

~ 0.06

a:

0.04

With 0.065 mM NADH

0.02

0.00

----.....----~-----.----"-'T"------.-----

0.0

2.0

4.0

6.0

8.0

10.0

12.0

[malate] (mM)

Figure 11.
Plot of rate vs. [malate] in the absence and presence of NADH for the
control eMDH that was not treated with FSBA
Conditions: 0.05 to 10.0 mM malate, 0.18 mM NAO+, 0 .065 mM NADH and
50 mM TAPS pH 9.0
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Chemical modification with FSBA Using 0.18 mM NAO+
in the Enzyme Assay
Modified eMDH
0.10
Km= 1.6 mM ± 0.13 (8.1%)
Vmax = 1.08 ± 2 .8 E-03 {0.3%)

0.09

Control

•

•

0.08
0.07
0.06
Q)

(ii 0.05

a:

With 0.065 mM NADH

0.04
0.03
0.02
0.01
0.00
0.0

2.0

4.0

6.0

8.0

10.0

12.0

[malate] (mM)

Figure 12.
Plot of rate vs. [malate] in the absence and presence of NADH for the
modified sample that was treated with FSBA.
Conditions: 0.05 to 10.0 mM malate, 0.18 mM NAO+, 0.065 mM NADH and
50 mM TAPS pH 9.0
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Chemical Modification with FSBA
Control eMDH that was not treated with FSBA
Conditions: 0.05to10.0 mM malate, 7 mM NAD•, 0.065 mM
NADH, and 50 mM TAPS pH 9.0
Malate cone. (mM)
Rate (LiOD/min)
Rate (LiOD/ min)
Control
With 0.065 mM NADH
0.05
0.018
0.001
Table 10.

0.10

0.051

0.0025

0.25

0.115

0.0038

0.50

0.147

0.009

1.00

0.200

0.042

2.00

0.211

0.058

5.00

0.222

0.101

10.00

NA

0.125

Chemical Modification with FSBA
Modified eMDH that was treated with FSBA
Conditions: 0.05 to 10.0 mM malate, 7 mM NAD·, 0.065 mM
NADH, and 50 mM TAPS pH 9.0
Malate cone. (mM)
Rate (LiOD I min)
Rate (LiOD/ min)
Control
With 0.065 mM NADH
0.018
0.006
0.05
Table 11.

0.10

0.031

0.011

0.25

0.069

0.031

0.50

0.104

0.047

1.0

0.149

0.080

2.0

0.167

0.101

5.0

0.170

0.128

10.0

0.180

0.137
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Chemical Modification with FSBA using 7 mM NAO+
in the Enzyme Assay
Control eMDH
0.30
0.25

Km = 0.32 mM ± 0.005 (1.6%)

Control

Vmax= 0.25 ± 0.01 (4%)

•

0.20
Q)

<ao.15

a:

0.065 mM NADH

0.10
0.05
0.00
0.0

2.0

4.0

6.0

8.0

10.0

12.0

[malate] (mM)

Figure 13.
Plot of rate vs. [malate] for the control eMDH that was not treated with FSBA
Conditions: 0.05 to 10.0 mM malate, 7 mM NAO +, 0.065 mM NADH, and 50
mM TAPS buffer pH 9.0
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Chemical Modification with FSBA using 7 mM NAO+
in the Enzyme Assay
Modified eMDH
0.25 - - - - - - - - - - - - - - - - - - - - - - - - - - - Control
Km = 0.4 ± 0.05 (12.5%)
Vmax 0.19 ± 6.05 E-03 (3.2%)
0.20
Control

=

•
0.15
Q)

•

•

<U

a:

With 0.065 mM NADH

0. 10

With 0.065 mM NADH
Km = 0.55 mM ± 0.03 (5.5%)
Vmax = 0.16 ± 0.027 (16.8%)

0.05

0.00

+-------.--------,.-----~-----T----.....-------i

0.0

2.0

4.0

6.0

8.0

10.0

[malate] (mM)

Figure 14.
Plot of rate vs. [malate] of the modified eMDH.
Condition: 0.05 to 10.0 mM malate, 7 mM NAO+, 0.065 mM NADH and 50 mM
TAPS buffer pH 9.0
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12.0

+ Chemical Modification with FSBA without protecting the active site:
This experiment was performed in order to determine the role that NADH
plays in protecting the active site from being modified by FSBA. The unprotected
MDH sample in this experiment consisted of: 1 mM FSBA in absolute ethanol,
690 nM eMDH, and 50 mM TAPS buffer pH 9.0. The protected enzyme sample
contained the same components, in addition to the presence of 0.lSmM NADH.
The results of this experiment are summarized in Table 12, and a plot of rate vs.
[malate] is presented in Figure 15.
Table 12. Rate data from the chemical modification with FSBA without
protecting the active site with NADH
Conditions: 0.05 to 5.0 mM malate, 7 mM NAD•, 50 mM TAPS pH 9.0
containing 100 mM KCl
Malate cone. (mM)
Rate (~OD/min)
Rate (LlOD I min)
protected eMDH
unprotected eMDH
0.018
0.05
0.005
0.036
0.010
0.1
0.072
0.25
0.022
0.5
0.089
0.030
1.0
0.105
0.055
0.147
2.0
0.066
0.153
0.075
5.0

As the data and Figure 15 show, there was approximately 50-60 % drop in
the catalytic activity when NADH was not added to the incubation mixture. This
data suggests that, in the presence of NADH, FSBA might be modifying a
specific amino acid residue in the allosteric site since the drop in rates was not
observed in the chemical modification experiment.
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Inactivation of eMDH by FSBA
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V max =0 .16 ± 8.5 E-03 (5.3%)

0.16

•

0.14
0 .12
Q)

•

0 .10

Unprotected eMDH

«i
0: 0.08

•

0.06
Unprotected eMDH

0.04

Km= 0.76 mM ± 0 .11 {14.5%)
Vmax

0.02
0 .00

=0.09 ± 4.3 E-03 (4.8%)

+------.-----...------....-----r------.-----'4
0.0

1.0

2.0

3 .0

4.0

5.0

6.0

[malate] (mM)

Figure15.
Plot of rate vs. [malate] of FSBA-modified eMDH with and without protecting th
active site.
Conditions: 0.05 to 5.0 mM malate, 7 mM NAO+, and 50 mM TAPS pH 9.0
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• The allosteric effect in the reverse direction:
The allosteric assay was performed in the direction of NADH oxidation.
Three different concentrations of NADH were used: 0.017 mM, 0.15 mM, and
0.32 mM. OAA concentration was varied from 0.003 to 0.16 mM. The enzyme
assays in the presence of 0.017 and 0.15 mM NADH were performed using the
stopped-flow spectrophotometer. The 0.32 mM NADH assay was performed on
the Shimadzu UV-3100 spectrophotometer, using 0.15 mM NADH as blank.
Table 13 shows the data obtained from the three enzyme assays. Figure 16 shows
the plots of rate vs. [OAA] using 0.017 and 0.15 mM NADH. Double reciprocal
plot of this data is presented in Figures 17a and 17b.
Rate data in the reverse direction.
Table 13.
Conditions: OAA was varied from 0.003 to 0.16 mM, NADH was fixed at
0.017, 0.15 and 0.32 mM, 50 mM Kpi buffer '.)H 7.2
OAAconc.
Rate (~OD/min) Rate (~OD/min) Rate (~OD/min)
(mM)
0.017 mM NADH 0.15mMNADH 0.32mMNADH
0.0139
NA
NA
0.003
0.0166
0.028
0.042
0.005
0.026
0.040
0.052
0.01
0.031
0.063
0.065
0.02
0.034
0.080
0.107
0.03
0.166
0.05
0.038
0.097
0. 121
0.08
0.037
0.198
0.122
0.16
NA
0.20
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The Enzyme Assay in the Reverse Direction ( OAA Reduction)
0.14
0.15 mM NADH
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Figure 16.
Plot of rate vs. [OAA] in the reverse direction in the presence of 0.017 and
0.15 mM NADH
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Double Reciprocal Plot of the Enzyme Assay in the Reverse Direction

Figure 17a.
1/v vs. 1/[0AA] in the presence of 0.017 mM NADH
70--~~~~~~~~~~~~~~~~~~~---.

Km= 0.01 mM ± 6.4 E-04 (6.4%)
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Figure 17b.
1/v vs. 1/[OAA] in the presence of 0.15 mM NADH
Km= 0.03 mM ± 3.4 E-03 (10%)
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Figure 17.
A plot of 1/v vs. 1/[0AA] in the presence of a) 0.017 mM,
and b) 0.15 mM NADH
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As noted in Figure 16, at 0.017 mM and 0.15 mM NADH the plots of the
rates against [OAA] are hyperbolic and follow Michaelis-Menten kinetics with
Km values of 0.01 mM and 0.03 mM OAA, respectively (Figures 17a and 17b).
However, the hyperbolic curve becomes sigmoidal in the presence of 0.32 mM
NADH (Figure 18), which suggests that at a higher concentration, NADH
allosterically regulates the catalytic activity of eMDH in the direction of OAA
reduction. The Hill constant in this direction is 1.6 and the Km value is 0.025 mM
OAA (Figure 19).

+ FSBA-modified enzyme activity in the reverse direction at pH 7.2:
This experiment was performed to examine whether the FSBA-modified
enzyme will exhibit the same behavior in the reverse direction as the forward
direction. The rates recorded in this experiment are summarized in Table 14. A
plot of this data is presented in Figures 20a and 20b.

Table 14. Rate data from the FSBA-modified eMDH at pH 7.2
Conditions: variable concentrations of OAA, 0.32 mM NADH, 50 mM
KPi buffer pH 7.2 containg 100 mM KCl and 2 mM EDTA
OAA cone. (mM)
Rate (~OD I min)
Rate (~OD I min)
Modified eMDH
Control eMDH
0.005
0.032
0.026
0.043
0.035
0.01
0.055
0.053
0.02
0.03
0.095
0.093
0.05
0.103
0.097
0.08
NA
0.10
0.102
0.110
0.16
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The Allosteric Effect of eMDH in the Reverse Direction
0.25 - -- - - - - - - - - - - - - - - - - - - - - - - - - - ,
0.32 mM NADH
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Figure 18.
Plot of rate vs. [OAA] in the reverse direction, in the presence of
0.32mMNADH
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0.18

The Hill Plot for eMDH in the Reverse Direction
slope= 1.59
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Figure19.
The Hill plot for eMDH in the reverse direction at 0.32 mM
NADH
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Chemical Modification with FSBA at pH 7.2

Figure 20a. The control eMDH that was not treated with FSBA
0.12 ~----------------------.
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Figure 20b. The modified eMDH that was treated with 1 mM FSBA
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Figure 20.
Plot of rate vs. [OAA] of FSBA-modified eMDH at pH 7.2
Conditions: 0.005 to 0.16 mM OAA, 0.32 mM NADH, and 50 mM KPi
buffer pH 7.2
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As Figures 20a and 20b show, the allosteric effect of eMDH in the reverse
direction seems to be unclear. The sigmoidal plot of rate vs. [OAA] of the control
enzyme sample that was not treated with FSBA is not as distinct as the first assay
(Figure 18). The fact that the reaction is much faster in this direction makes the
detection of the initial rates using the UV-3100 Shimadzu spectrophotometer not
reliable, particularly at low OAA concentrations. The enzyme assay at 0.32 mM
NADH was performed using the stopped-flow spectrophotometer. However, the
plots of absorbance vs. time were noisy since a blank of 0.15 mM NADH was not
used and the change of absorbance was very small at low [OAA].

+ The results of protein lyophilization:
The routine enzyme assay in the reverse direction was used to determine
the effect of the lyophilization procedure on the specific activity of eMDH. The

lyophilized protein was reconstituted in 0.6 mL D20. Table 15 shows a summary
of this data.

Table 15. Effect of lyophilization on eMDH

Before
lyophilization
First treatment
Second treatment

eMDH
concentration
(u/mL)
3870

Protein
concentration
(mg/mL)
3.5

Specific Activity
(u/ mg)

6917
2714

6.9
4.1

1002 (90.1 %)
662 (66.1%)
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1105

1
•

H NMR spectra:
1

H NMR spectra were recorded using the lyophilized protein. The first

spectrum that was recorded using 496 acquisitions at 2fC (Figure 21) showed a
very intense water peak, which did not allow the detection of other peaks in the
spectrum. Therefore, the protein was relyophilized and reconstituted in 0.6 mL
fresh D 20 to minimize the exchange of deuterium with protons. The second
spectrum was recorded using 10512 acquisitions to improve the signal-to-noise
ratio. However, this did not reduce the intensity of the 18iO peak (Figure 22). A
1

water suppression technique in order to subtract the H 20 signal needs to be used
in this experiment, which will allow the observation Qf the other proton signals.
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Figure 21
1H NMR spectrum of eMDH in D20
The experiment was carried out using 496 acquisitions at 25·c
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Figure 22
IH spectrum of eMDH in D20
The experiment was performed using 10512 acquisitions at 2s·c

54

I

ppm

Chapter IV

Discussion

The data presented in this research supports the proposal that eMDH is
allosterically regulated by NADH in the direction of NAD• reduction. Other
nucleotides including ATP, ADP, and AMP were found to bring about the same
effect [7]. However, the high concentration required for this effect makes it
unlikely that they are involved in the regulation of eMDH in vivo.

+ Allosteric Effect in the forward direction:
When malate was the variable substrate in the presence of 0.065 mM
NADH, a plot of v against [MAL] resulted in a sigmoidal curve, which reflects
the allosteric behavior of eMDH (Figure 5). These results suggest that eMDH has
an allosteric site, which is different from the active site, where NADH and
possibly the other nucleotides bind and change the catalytic activity of the
enzyme.
Since a plot of absorbance vs. time at low substrate concentration is linear
for only few seconds, the rates recorded on the Shimadzu spectrophotometer
might not be the actual initial rates. This might result in misinterpreting the data
with respect to the allosteric effect since the recorded rates will be lower that the
actual initial rates. Therefore, the experiment was repeated using the stoppedflow spectrophotometer, in addition to using lower concentrations of the
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substrate (MAL). This data has further supported the proposal of the allosteric
behavior of eMDH, since a sigmoidal curve was obtained in a plot of rate vs.
[MAL] (Figure 9). Both the stopped-flow and the conventional techniques seem
to be comparable, as far as the forward direction is concerned, since using lower
concentrations of MAL resulted in a sigmoidal curve.
An interpretation of this data according to the MWC theory could be
based on the following suggestions:
1. Binding of NADH at the allosteric site causes conformational changes in the
subunits and, therefore, changes the catalytic properties of the active site. This
assumption is based on the observed increase of Km value (from 1.3 to 3.9 mM
malate), which indicates a decrease in the enzyme affinity for the substrate.
2. Based on the MWC model, NADH seems to preferentially bind to the T state
of eMDH and, thereby, increases the T /R ratio by inhibiting the transition to
the R state.
3. Since NADH is a product of the reaction in this direction, product inhibition,
in addition to the allosteric inhibition was observed. This explains the drop of
Vmax that accompanied the increase of Km.
4. A Hill constant value of 1.2 was obtained when v /V m•x -v was graphed against
log [MAL], which suggests the presence of positive cooperativity between the
allosteric and the active sites.

56

•

The Chemical Modification at pH 9.0:
FSBA was utilized as an analog of NAD•, NADH, ATP, and ADP in

modifying the binding sites of these nucleotides in several enzymes. This
compound is believed to chemically modify specific amino acid residues,
including tyrosine, histidine, lysine, serine, and cysteine [16]. The sulfonyl
fluoride is the reactive functional group, which acts as an electrophile that is
attacked by these amino acids.
The modification process can take place by different mechanisms.
Tyrosine and lysine covalently react with FSBA to yield stable derivatives [10].
When these derivatives were treated with 6 M HCl, the ester linkage between the
benzoyl and the nucleoside moieties was cleaved, producing two acid-stable
compounds, N-(4-carboxybenzenesulphonyl) lysine and
0-(4-carboxybenzenesulphonyl) tyrosine. These two compounds are
characterized by their hydophobicity and a net negative charge at neutral pH. A
proposed mechanism for this type of modification is presented in Scheme 2
where Nu· represents the amino acid residue that is being modified and R is the
adenosine moiety.

IT-Q-IT
j
c-oR

IT-Q-ITc-oR

t~ ~

Nu-~

~

;}

+

0

Nu·

Scheme 2.
A proposed mechanism for the covalent modification with FSBA
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F·

Another mechanism that does not involve covalent modification by FSBA
involves the formation of a disulfide between two adjacent cysteine residues.
This mechanism is believed to be involved in the FSBA-modified
S-adenosylhomcysteinase since the inactivation was linearly related to the loss of
sulfhydryl groups but none of the FSBA was covalently bound to the enzyme
[17].

eMDH was treated with FSBA in order to determine whether this
modification will affect the allosteric behavior of the enzyme. The results from
these experiments suggest that, in the presence of 0.15 mM NADH as a
protecting agent, FSBA may modify a specific amino acid at the allosteric site
since the allosteric behavior was abolished (Figures 7 & 14). Since modification
with FSBA is specific to tyrosine, histidine, lysine, cysteine, and/ or serine, this
data implies that one or more of these amino acids may be involved in binding of
NADH at the allosteric site. When eMDH was treated with FSBA in the absence
of NADH, approximately 50 % of the enzyme activity was lost (FigurelS). This
observation indicates that NADH protects the active site against the inactivation
byFSBA.
Although the FSBA-modified eMDH did not exhibit the allosteric effect in
the presence of NADH, it is not clear from this data whether FSBA is modifying
the putative allosteric site or other amino acid residues that might interact with
this site. Further experiments with respect to this modification may involve
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analyzing the modified eMDH using an amino acid analysis technique to
identify the residues that are modified by FSBA. In addition, incorporation of
radioactive FSBA can be utilized in determining the stoichiometry of the reaction
between the enzyme and the modifying agent.
• The Allosteric Effect in the reverse direction:
An allosteric effect in the direction of OAA reduction was observed at 0.32

mM NADH (Figure 16), with a Hill constant of 1.6 (Figure 17). In contrast to

Sanwal's observation (the rates were measured using a Gilford 2000 recording
spectrophotometer) [8], the rates recorded on the stopped-flow
spectrophotometer at 0.15 mM NADH when OAA was the variable substrate
were not sigmoidal, but instead followed Michaelis-Menten kinetics with Km
value of 0.03 mM OAA (Figure lSb).
• The Chemical modification at pH 7.2:
eMDH was incubated with FSBA at pH 7.2 in order to determine whether
the modified enzyme will exhibit the same behavior in the reverse direction as in
the forward direction. However, the sigmoidal curve in the presence of 0.32 mM
NADH when OAA was the variable substrate (Figure 17a) was not as clear as
data presented in Figure 16. Therefore, it could not be confirmed whether NADH
allosterically regulates the reaction catalyzed by NADH in the reverse direction.
Since the reaction rates are much faster in this direction, and in the presence of
0.32 mM NADH, the change in absorbance is very small particularly at low OAA
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concentrations, obtaining the initial reaction rates using the routine
spectrophotometers might not be reliable.

+ Protein Lyophilization and 1H NMR data:
The results obtained from the activity and protein assays of the
lyophilized protein indicates that eMDH is stable under the conditions of
lyophilization since only 10 % of the specific activity was lost. However, when
the protein was relyophilized, the loss of the activity became more severe (34%).
The 1H NMR spectra did not reveal any signals that might be significant
1

because of the intensity of HiO signal. Applying a water suppression technique
seems to be important in this experiment particularly at low protein
concentration.
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